Latest Drug Approvals news
FDA Expands Use of Vonvendi for Von Willebrand Disease
posted September 8th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves Subcutaneous Leqembi for Treatment of Early Alzheimer Disease
posted September 2nd
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves Papzimeos for Adults With Recurrent Respiratory Papillomatosis
posted August 21st
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves Sublingual, Nonopioid Daily Treatment for Fibromyalgia
posted August 20th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Paternal Exposure to Valproate Not Linked to Offspring Neurodevelopmental Disorders 
Drug Retention in Spondyloarthritis Varies With Socioeconomic Status 
Chemo-Free Combo of Four Targeted Therapies Shows Promise in Metastatic Breast Cancer 
December 2024 to 2025 Saw Significant Increase in Leucovorin Dispensing Related Articles
Countries Involved in U.S. Clinical Trials Do Not Gain Timely Access to Approved Medicines 
FDA Picks George Tidmarsh to Head Center for Drug Evaluation and Research 
Approved-Label Populations for New Drugs Broader Than Trial Populations Monthly Specialist Briefings
Stay Connected
